1 The CAPRIE Study Group, "trial of clopidogrelversus aspirin in patients at high risk of ischemic events" lancet1996;348
2 Molina V, "a potentialantithrombotic compound isolated from sugar cane waxwith effects on arachidonic acid metabolites" -003, prostaglandinsleukotessentfattyacids2002;6719?24
3 Molina V, "Synergistic effectof D-003 and aspirin on experimental thrombosis models" prostaglandinsleukotessentfattyacids2003;68
4 Cowan DH, "Role of plasme" brjhaematol1981;47
5 Creager MA, "Results of the CAPRIE trial Clopidrogel versus aspirin in patients at risk of ischaemicevents" vascmed1998;3
6 Coller B, "Platelet-active drugs: The relationships among dose, effectiveness, and side effects" patro (patro): 1-, chest2001;119
7 Cowan DH, "Platelet adherence to collagen Role of prostaglandin?thromboxane synthesis" brjhaematol1981;49
8 Moncada S, "PgX or PgI2 by layers of the arterial wall An explanation for the anti-thrombotic properties of vascular endothelium"
9 Marrero D, "Mixture of primary fatty acids of high molecular weight obtainedfrom sugar cane wax and its pharmaceutical uses" 1997
10 Anzini A, "Long-term prognosis after a minor stroke 10-year mortality and major stroke recurrence rates in a hospitalbasedcohort" stroke1998;29
1 The CAPRIE Study Group, "trial of clopidogrelversus aspirin in patients at high risk of ischemic events" lancet1996;348
2 Molina V, "a potentialantithrombotic compound isolated from sugar cane waxwith effects on arachidonic acid metabolites" -003, prostaglandinsleukotessentfattyacids2002;6719?24
3 Molina V, "Synergistic effectof D-003 and aspirin on experimental thrombosis models" prostaglandinsleukotessentfattyacids2003;68
4 Cowan DH, "Role of plasme" brjhaematol1981;47
5 Creager MA, "Results of the CAPRIE trial Clopidrogel versus aspirin in patients at risk of ischaemicevents" vascmed1998;3
6 Coller B, "Platelet-active drugs: The relationships among dose, effectiveness, and side effects" patro (patro): 1-, chest2001;119
7 Cowan DH, "Platelet adherence to collagen Role of prostaglandin?thromboxane synthesis" brjhaematol1981;49
8 Moncada S, "PgX or PgI2 by layers of the arterial wall An explanation for the anti-thrombotic properties of vascular endothelium"
9 Marrero D, "Mixture of primary fatty acids of high molecular weight obtainedfrom sugar cane wax and its pharmaceutical uses" 1997
10 Anzini A, "Long-term prognosis after a minor stroke 10-year mortality and major stroke recurrence rates in a hospitalbasedcohort" stroke1998;29
11 Carbajal D, "Effectsof policosanol on platelet aggregation in rats"
12 Carbajal D, "Effects of D-003 a new compound purified from sugarcanewax on platelet aggregation in healthy volunteers" clindruginvest2003;23
13 "Collaborative overview ofrandomized trials of antiplatelet therapy?I Prevention of death myocardial infarction and stroke by prolonged antiplatelet therapyin various categories of patients" bmj1994;308
14 Harbison JW, "Clinical considerations in selecting antiplatelet therapyin cerebrovascular disease" amjhealthsystpharm1998;55
15 Arroyo MT, "Aspirin related gastrointestinal bleeders have an exaggeratedbleeding time response due to aspirin use" gut1996;39
16 Hassan M, "Aspirin for primary and secondary prophylaxisof cardiovascular disease"
17 Bunting S, "Arterial wallsgenerate from prostaglandin endoperoxides a substance which relaxesstrips of mesenteric and celiac arteries and inhibits plateletaggregation" prostaglandins1976;12
18 Cairns JA, "Antithromboticagents in coronary artery disease" 4-, chest1995;108
19 Sherman D, "Antithrombotic therapy for cerebrovascular disorders" 4-, chest1995;108
20 Molina V, "Antiplateletand antithrombotic effects of D-003" pharmacolres2000;42
21 Schafer A, "Antiplatelet therapy" amjmed1996;101199?209
22 McTavish D, "An updated reviewof its pharmacology and therapeutic use in platelet-dependent disorders" drugs1990;40
23 Landmark K, "Acetylsalicylic acid in the treatment of cardiovascularand cerebrovascular diseases Tidsskr Nor Laegeforen 1997;117"
24 Puri RN, "ADP-induced platelet activation." 1997
25 Hamberg M, "A newgroup of biologically active compounds derived from prostaglandinendoperoxides"
26 Salem DN, "A cohort analysis fromthe Studies of Left Ventricular Dysfunction" jamcollcardiol1998;31